Clinical adoption of an artificial intelligence–enabled imaging tool requires critical appraisal
of its life cycle from development to implementation by using a systematic, standardized, and …

Purpose Artificial intelligence (AI) has emerged as a transformative force in medical
research and is garnering increased attention in the public consciousness. This represents a …

Artificial intelligence (AI) is a branch of computer science with a variety of subfields and
techniques, exploited to serve as a deductive tool that performs tasks originally requiring …

Fueled by new techniques, computational tools, and broader availability of imaging data,
artificial intelligence has the potential to transform the practice of neuroradiology. The recent …

Artificial intelligence (AI)-based tools are gradually blending into the clinical neuroradiology
practice. Due to increasing complexity and diversity of such AI tools, it is not always obvious …

Purpose To conduct a systematic review of the possibilities of artificial intelligence (AI) in
neuroradiology by performing an objective, systematic assessment of available applications …

Discussion As depicted in the main table, the majority of FDA-approved AI products are
developed by companies headquartered in Europe and the North America. Another …

Medical costs in the United States continue to exceed 17% of the Gross Domestic Product
each year or more than $2 trillion, greater than any other country. 1 Although computed …

Background Artificial intelligence (AI) in medicine has shown significant promise, particularly
in neuroimaging. AI increases efficiency and reduces errors, making it a valuable resource …

Over the past decade, machine learning (ML) and artificial intelligence (AI) have become
increasingly prevalent in the medical field. In the United States, the Food and Drug …